zirconium has been researched along with Cell Transformation, Neoplastic in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (81.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, SH; Boros, E; Hallam, TJ; Lupher, ML; Solis, WA; Vaughn, BA | 1 |
| Cullinane, C; Donnelly, PS; Haskali, MB; Hicks, RJ; Noor, A; Roselt, PD; Rudd, SE; Van Zuylekom, JK; Waldeck, K; Wheatcroft, MP; Yan, E | 1 |
| de Vries, EGE; Giesen, D; Kol, A; Lub-de Hooge, MN; Pool, M; Terwisscha van Scheltinga, AGT | 1 |
| Abdel-Atti, D; Dilling, TR; Edwards, KJ; Evans, MJ; Henry, KE; Lewis, JS | 1 |
| Bhattacharyya, S; Doroshow, JH; Hill, GC; Jacobs, PM; Kalen, JD; Kaur, G; Kurdziel, K; Riffle, L; Tatum, JL; Wei, L | 1 |
| Koizumi, M; Kurosawa, G; Kurosawa, Y; Nagatsu, K; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Ukai, Y; Zhang, MR | 2 |
| de Vries, EG; Herting, F; Lub-de Hooge, MN; Oude Munnink, TH; Tamas, KR; Tessier, J; Timmer-Bosscha, H; Vedelaar, SR; Walenkamp, AM; Weidner, KM | 1 |
| Carlin, S; Drobjnak, M; Evans, MJ; Lewis, JS; Livingston, PO; Ragupathi, G; Rice, SL; Sawada, R; Scholz, WW; Sevak, KK; Viola-Villegas, NT; Wu, X | 1 |
| Daiji, M; Huang, C; Ikotun, OF; Lapi, SE; Marquez, BV; Masuko, K; Masuko, T; McConathy, J | 1 |
| Knowles, SM; Reiter, RE; Rochefort, MM; Salazar, FB; Stout, DB; Tavaré, R; Wu, AM; Yazaki, PJ; Zettlitz, KA | 1 |
| Li, K; Mallick, P; Marks, JD; Mumenthaler, SM; Tavaré, R; Wu, AM; Zettlitz, KA; Zhou, Y | 1 |
| Cornelissen, B; Falzone, N; Fernández-Varea, JM; Kersemans, V; Knight, JC; Mosley, M; Topping, C | 1 |
| Carlin, SD; Knight, JC; Lewis, JS; Monette, S; Sala, E; Sevak, KK; Sharma, SK; Wuest, FR; Zeglis, BM | 1 |
| Behnam Azad, B; Chatterjee, S; Lisok, A; Luker, GD; Nimmagadda, S; Poirier, JT; Pomper, MG; Pullambhatla, M | 1 |
| Burvenich, IJ; Gan, HK; Gong, S; Guo, N; Hasegawa, J; Kotsuma, M; Lee, FT; Lee, ST; O'Keefe, GJ; Parakh, S; Rigopoulos, A; Scott, AM; Senaldi, G; Tochon-Danguy, H | 1 |
| Barnhart, TE; Cai, W; Cho, SY; Dunphy, EJ; England, CG; Hernandez, R; Im, HJ; Kamkaew, A; Lee, DS; Sun, H; Valdovinos, HF | 1 |
| Blosi, M; Coppedè, F; Costa, AL; Di Bucchianico, S; Migliore, L; Ortelli, S; Placidi, C; Ponti, J; Stoccoro, A; Uboldi, C | 1 |
| Arjaans, ME; de Vries, EG; Gregory, RC; Hesselink, JW; Lub-de Hooge, MN; Oude Munnink, TH; Reiss, M; Schröder, CP; Timmer-Bosscha, H; Vedelaar, SR; Walenkamp, AM | 1 |
| Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK | 1 |
| Andreassi, C; Bruzzese, N; Burger, W; Cittadini, A; Covacci, V; Maccauro, G; Marmo, E; Piconi, C; Ricci, GA | 1 |
| Shvemberger, IN | 1 |
1 review(s) available for zirconium and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
[Epigenetic variability of somatic cells in non-neoplastic processes (as exemplified by epithelioid cells)].
Topics: Allergens; Animals; BCG Vaccine; Beryllium; Cell Transformation, Neoplastic; Connective Tissue; Connective Tissue Cells; Genetic Variation; Granuloma; Humans; Leprosy; Macrophages; Mice; Mineral Oil; Mitosis; Rats; Rheumatic Fever; Rheumatic Heart Disease; Sarcoidosis; Toxoplasmosis; Tuberculosis; Zirconium | 1973 |
21 other study(ies) available for zirconium and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Site-Specific
Topics: Alkynes; Amino Acids; Animals; Azides; Cell Line, Tumor; Cell Transformation, Neoplastic; Cycloaddition Reaction; Humans; Immunoconjugates; Indium Radioisotopes; Isotope Labeling; Mice; Radioisotopes; Zirconium | 2020 |
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Topics: Animals; Antigens, Surface; Cell Line, Tumor; Cell Transformation, Neoplastic; Deferoxamine; Enzyme Inhibitors; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Isotope Labeling; Male; Mice; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Quinine; Radioisotopes; Tissue Distribution; Zirconium | 2020 |
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Feasibility Studies; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Radioisotopes; Resorcinols; Up-Regulation; Zirconium | 2017 |
Noninvasive
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Radioisotopes; Transferrin; Triple Negative Breast Neoplasms; Zirconium | 2018 |
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoconjugates; Isotope Labeling; Male; Mice; Panitumumab; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Radiometry; Zirconium | 2013 |
Evaluation of (89)Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Basigin; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Humans; Male; Mice; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Zirconium | 2013 |
Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Transport; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Kidney Neoplasms; Macrophages; Male; Mice; Placenta Growth Factor; Pregnancy Proteins; Radioisotopes; Tumor Microenvironment; Zirconium | 2013 |
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Topics: Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Mice; Neoplasms; Positron-Emission Tomography; Radioisotopes; Zirconium | 2013 |
Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET.
Topics: Animals; Antibodies, Monoclonal; Cell Transformation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; Isotope Labeling; Large Neutral Amino Acid-Transporter 1; Male; Mice; Positron-Emission Tomography; Radioisotopes; Rats; Zirconium | 2013 |
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.
Topics: Animals; Artifacts; Cell Line, Tumor; Cell Transformation, Neoplastic; Iodine Radioisotopes; Isotope Labeling; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Single-Chain Antibodies; Zirconium | 2014 |
Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Female; Heterografts; Humans; Immunoglobulin Fragments; Lung Neoplasms; Mice; Mice, SCID; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Radioisotopes; Radiopharmaceuticals; Zirconium | 2014 |
Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Mice; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptors, Transferrin; Tissue Distribution; Zirconium | 2015 |
PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
Topics: Animals; Antibodies, Monoclonal; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Breaks, Double-Stranded; Female; Gene Products, tat; Histones; Humans; Immunoconjugates; Mice; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2015 |
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Topics: Animals; Antibodies, Monoclonal; CA-125 Antigen; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Immunoconjugates; Lymphatic Metastasis; Membrane Proteins; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2016 |
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Topics: Animals; Antibodies, Monoclonal; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Mice; Molecular Imaging; Positron-Emission Tomography; Radioisotopes; Receptors, CXCR; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Zirconium | 2016 |
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Deferoxamine; Female; Humans; Isothiocyanates; Mice; Pentetic Acid; Positron-Emission Tomography; Quality Control; Radioisotopes; Receptor, EphA2; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Zirconium | 2016 |
ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptor, IGF Type 1; Tissue Distribution; Zirconium | 2016 |
A panel of in vitro tests to evaluate genotoxic and morphological neoplastic transformation potential on Balb/3T3 cells by pristine and remediated titania and zirconia nanoparticles.
Topics: Animals; Cell Line; Cell Survival; Cell Transformation, Neoplastic; DNA; DNA Damage; Metal Nanoparticles; Mice; Mutagenicity Tests; Oxidative Stress; Titanium; Zirconium | 2016 |
PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Liver; Male; Mice; Neoplasm Metastasis; Positron-Emission Tomography; Radioisotopes; Transfection; Transforming Growth Factor beta; Zirconium | 2011 |
PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Diagnostic Imaging; ErbB Receptors; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Panitumumab; Peritoneal Neoplasms; Positron-Emission Tomography; Protein Transport; Radiochemistry; Radioisotopes; Risk Assessment; Zirconium | 2012 |
In vitro evaluation of the mutagenic and carcinogenic power of high purity zirconia ceramic.
Topics: Animals; Biocompatible Materials; Carcinogens; Cell Adhesion; Cell Division; Cell Line; Cell Transformation, Neoplastic; Ceramics; Dental Materials; Embryo, Mammalian; Mice; Mutagenicity Tests; Mutagens; Zirconium | 1999 |